Gene Therapy
Gene Therapy
Gene Therapy
Presented by Mankaran Singh, Dinesh Kumar, Deepak Sharma, Gurmeet Singh M.Pharmacy PHARMACEUTICS CT Institute of Pharmaceutical sciences Jalandhar, INDIA AICTE , PCI approved
Genes
Are carried on a chromosome
Picture of a Chromosome
How It Works
A vector delivers the therapeutic gene into a patients target cell The target cells become infected with the viral vector The vectors genetic material is inserted into the target cell Functional proteins are created from the therapeutic gene causing the cell to return to a normal state
VIRAL VECTORS
1. Adenoviral vectors:
Double-stranded DNA viruses, usually cause benign respiratory disease; serotypes 2 and 5 are used as vectors. Can infect dividing and non-dividing cells, can be produced at high titers. Replication-deficient adenovirus vectors can be generated by replacing the E1 or E3 gene, which is essential for replication.
The recombinant vectors are then replicated in cells that express the products of the E1 or E3 gene and can be generated in very high concentrations.
Cells infected with recombinant adenovirus can express the therapeutic gene, but because essential genes for replication are deleted, the vector cant replicate.
AAV vectors:
To produce an AAV vector, the rep and cap genes are replaced with a transgene. The total length of the insert cannot exceed 4.7 kb, the length of the wild type genome.
Production of the recombinant vector requires that rep and cap are provided in trans along with the helper virus gene products.
The current method is to cotransfect two plasmids, one for the vector and another for rep and cap into cells infected with adenovirus. This method is cumbersome, low yielding and prone to contamination with adenovirus and wild type AAV. Interest in AAV vectors is due to their integration into the host genome allowing prolonged gene expression.
3.Retroviral vectors:
Retroviral vectors are based on Moloney murine leukemia virus (Mo-MLV) which is capable of infecting both mouse and human cells. The viral genes, gag, pol and env, are replaced with the transgene of interest and expressed on plasmids in the packaging cell line. Because the non-essential genes lack the packaging sequence, they are not included in the virion particle. To prevent recombination resulting in replication competent retroviruses, all regions of homology with the vector backbone is removed.
Problems with expression being shut off, prolonged expression is difficult to attain.
Expression is reduced by inflammatory interferons acting on viral LTRs, as the retroviral DNA integrates, viral LTR promoters are inactivated.
4. Lentiviral Vectors
Belong to the retrovirus family but can infect both dividing and nondividing cells. They are more complicated than retroviruses, containing an additional six proteins, tat, rev, vpr, vpu, nef and vif. Human immunodeficiency virus (HIV) has been disabled and developed as a vector for in vivo gene delivery. Low cellular immune response, thus good possibility for in vivo gene delivery with sustained expression over six months.
THANK YOU